Turning Points: Scientists Who Leave the Bench Stay Away Forever

You can never go home again. Sources for my book on alternate careers told me the switch falls in one direction only.1I never dreamed of going back because writing allows me to learn about subjects as different as conservation research and the Y chromosome. Janet Joy, a senior program officer at the National Research Council (NRC) since 1995, says she has no plans to return to the bench either. Before heading to work at the NRC, she was a neuroscientist at the National Institute of Mental Healt

Written byKaren Young Kreeger
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Janet Joy, a senior program officer at the National Research Council (NRC) since 1995, says she has no plans to return to the bench either. Before heading to work at the NRC, she was a neuroscientist at the National Institute of Mental Health. Can you go back? I asked her. "No. I'm seven years out and I still give the same answer."

For Joy and others, the only reentry status they see for themselves would be as postdoctoral trainees, because they would need to refresh their knowledge. After finding a highly satisfying niche for herself at NRC, Joy says, "I have no desire to go back to that status."

Some practical problems also prevent people from returning to research. With each passing year, a former scientist moves further from publishing and funding networks. New discoveries open new technologies. "Science moves very quickly," says Maria Betty, a bioinformatics scientist for Wyeth ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies